1. Acute Renal failure caused by plasma cell infiltration in primary plasma cell leukemia. Issue 9 (9th August 2017) Authors: Liu, Yueming; Jin, Lai; Lan, Jianping Journal: Nephrology Issue: Volume 22:Issue 9(2017) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bone marrow stromal cells derived exosomal miR-10a and miR-16 may be involved in progression of patients with multiple myeloma by regulating EPHA8 or IGF1R/CCND1. Issue 4 (29th January 2021) Authors: Peng, Ye; Song, Xiaolu; Lan, Jianping; Wang, Xiaogang; Wang, Manling Other Names: Eskazan. Ahmet Emre section editor. Journal: Medicine Issue: Volume 100:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study. (4th March 2017) Authors: Tan, Yamin; Xiao, Haowen; Wu, Depei; Luo, Yi; Lan, Jianping; Liu, Qifa; Yu, Kang; Shi, Jimin; He, Jingsong; Zheng, Weiyan; Lai, Xiaoyu; Zhu, Yuanyuan; Du, Kaili; Ye, Yishan; Zhao, Yanmin; Zheng, Gaofeng; Hu, Yongxian; Han, Xiaoyan; Zheng, Yanlong; Wei, Guoqing Journal: Oncoimmunology Issue: Volume 6:Number 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Empirical polymyxin B therapy in febrile neutropenic patients with hematological diseases: A prospective, multicenter, observational clinical study. Issue 4 (April 2023) Authors: Ma, Liya; Shen, Jianping; Jiang, Huifang; Qian, Shenxian; Zhang, Jin; Lan, Jianping; Zhou, Hua; Lang, Wei; Mei, Chen; Zhou, Xinping; Zhu, Lixia; Xu, Gaixiang; Ye, Li; Hu, Chao; Ren, Yanling; Yang, Xiudi; Jin, Jie; Ye, Xiujin; Tong, Hongyan Journal: Journal of infection Issue: Volume 86:Issue 4(2023) Page Start: 406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher‐risk myelodysplastic syndromes: a prospective multicenter single‐arm trial. Issue 4 (24th June 2020) Authors: Zhou, Xinping; Mei, Chen; Zhang, Jin; Lu, Ying; Lan, Jianping; Lin, Shengyun; Zhang, Yuefeng; Kuang, Yuemin; Ren, Yanling; Ma, Liya; Wei, Juying; Ye, Li; Xu, Weilai; Li, Kongfei; Lu, Chenxi; Jin, Jie; Tong, Hongyan Journal: Hematological oncology Issue: Volume 38:Issue 4(2020) Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Identification of a Seven-lncRNA-mRNA Signature for Recurrence and Prognostic Prediction in Relapsed Acute Lymphoblastic Leukemia Based on WGCNA and LASSO Analyses. (9th June 2021) Authors: Qi, Haiyan; Chi, Long; Wang, Xiaogang; Jin, Xing; Wang, Wensong; Lan, Jianping Other Names: Urzua Ulises Academic Editor. Journal: Analytical cellular pathology Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis. (6th October 2022) Authors: Song, Xiaolu; Chen, Yirui; Peng, Ye; Wang, Xiaogang; Zheng, Sujie; Shi, Fangfang; Lan, Jianping Other Names: Zhang Peng-Yue Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long non‐coding RNA SNHG16 has Tumor suppressing effect in acute lymphoblastic leukemia by inverse interaction on hsa‐miR‐124‐3p. Issue 1 (31st October 2018) Authors: Yang, Tianxin; Jin, Xing; Lan, Jianping; Wang, Wensong Journal: IUBMB life Issue: Volume 71:Issue 1(2019) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma. Issue 20 (10th July 2022) Authors: Wang, Ying; Cao, Jiang; Gu, Weiying; Shi, Ming; Lan, Jianping; Yan, Zhiling; Jin, Lai; Xia, Jieyun; Ma, Sha; Liu, Yang; Li, Hujun; Pan, Bin; Chen, Wei; Fei, Xiaoming; Wang, Chunling; Xie, Xiaobao; Yu, Liang; Wang, Gang; Li, Huizhong; Jing, Guangjun Journal: Journal of clinical oncology Issue: Volume 40:Issue 20(2022) Page Start: 2246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma. Issue 20 (10th July 2022) Authors: Wang, Ying; Cao, Jiang; Gu, Weiying; Shi, Ming; Lan, Jianping; Yan, Zhiling; Jin, Lai; Xia, Jieyun; Ma, Sha; Liu, Yang; Li, Hujun; Pan, Bin; Chen, Wei; Fei, Xiaoming; Wang, Chunling; Xie, Xiaobao; Yu, Liang; Wang, Gang; Li, Huizhong; Jing, Guangjun Journal: Journal of clinical oncology Issue: Volume 40:Issue 20(2022) Page Start: 2246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗